Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value

Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value

The global epidemic of Metabolic dysfunction-associated fatty liver disease (MAFLD) urgently demands breakthroughs in precision medicine strategies. Its pathogenesis centers on the cascade dysregulation of the gut microbiota-metabolite-liver axis: microbial dysbiosis drives hepatic lipid accumulatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Luyu Wang, Hongtao Wang, Jian Wu, Changyi Ji, Ying Wang, Mengmeng Gu, Miaomiao Li, Hongwei Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
metabolic dysfunction-associated fatty liver disease (MAFLD)
gut microbiota
metabolomics
gut-liver axis
precision medicine
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1635638/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items